ANTAGONISTES LINGO-1 ET AGONISTES TRKB POR LEUR UTILISATION DANS LE TRAITEMENT DU GLAUCOME
- 专利权人:
- BIOGEN MA INC.
- 发明人:
- 申请号：
- EP08837617.3
- 公开号：
- EP2205071B1
- 申请日:
- 2008.10.10
- 申请国别(地区):
- EP
- 年份:
- 2015
- 代理人:
- 摘要：
- This invention relates to methods for promoting neuronal survival and regeneration using LINGO-1 antagonists and TrkB agonists. Additionally, the invention relates to methods for treating pressure induced optic neuropathies using LINGO-1 antagonists. The invention also relates generally to methods for increasing TrkB activity and inhibiting JNK pathway signaling using a LINGO-1 antagonist.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Methods for treating pressure induced optic neuropathy, preventing neuronal degeneration and promoting neuronal cell, survival via administration of lingo-1 antagonists and TrkB agonists
- Methods for Treating Pressure Induced Optic Neuropathy, Preventing Neuronal Degeneration and Promoting Neuronal Cell Survival Via Administration of Lingo-1 Antagonists and TrkB Agonists
- METHOD FOR TREATING PRESSURE INDUCED OPTIC NEUROPATHY, PREVENTING NEURONAL DEGENERATION AND PROMOTING NEURONAL CELL SURVIVAL VIA ADMINISTRATION OF LINGO-1 ANTAGONIST AND TrkB AGONIST
- How to treat the pressure-induced optic neuropathy through administration of LINGO-1 antagonists and TrkB agonists, to prevent neuronal degeneration and promote survival of neuronal cells
- PROCÉDÉS DESTINÉS À TRAITER LA NEUROPATHIE OPTIQUE INDUITE PAR LA PRESSION, À PRÉVENIR LA DÉGÉNÉRESCENCE NEURALE ET À PROMOUVOIR LA SURVIE DES CELLULES NEURONALES PAR LE BIAIS DE L'ADMINISTRATION D'ANTAGONISTES LINGO-1 ET D'AGONISTES TRKB
